A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.

Title:	A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.
Authors:	Mpendo, J Mutua, G Nyombayire, J Ingabire, R Nanvubya, A Anzala, O Karita, E Hayes, P Kopycinski, J Dally, L Hannaman, D Egan, MA Eldridge, JH Syvertsen, K Lehrman, J Rasmussen, B Gilmour, J Cox, JH Fast, PE Schmidt, C
Item Type:	Journal Article
Issue Date:	7-Aug-2015
Date of Acceptance:	6-Jul-2015
URI:	http://hdl.handle.net/10044/1/25820
DOI:	https://dx.doi.org/10.1371/journal.pone.0134287
ISSN:	1932-6203
Publisher:	Public Library of Science
Journal / Book Title:	PLOS One
Volume:	10
Issue:	8
Copyright Statement:	© 2015 Mpendo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Publication Status:	Published
Article Number:	e0134287
Appears in Collections:	Department of Medicine (up to 2019)

This item is licensed under a Creative Commons License